6.1.2 Antidiabetic drugs

Homepage

Search the NeLM

Medicines A-Z

Find key information about medicines by name (prototype)

Browse by Categories:

Browse by NeLM area:

BNF Category

594 library items in 6.1.2 Antidiabetic drugs

Filter results by:

Date Published

NeLM Area

News
Other Library Updates
Health In Focus
Evidence
Medicines A-Z
Communities
Formularies

Results filtered by:

Category

6: Endocrine system (remove) , 6.1 Drugs used in diabetes (remove) , 6.1.2 Antidiabetic drugs (remove)

Sort by: Display summary:

Results 1 - 10 of 594

Result page:
Previous
|
1
2
3
4
5
6
7
8
9
10
11
|
Next

1.

Diabetes clinical trials: helped or hindered by the current shift in regulatory requirements?

Source: Eur Heart J,
Date published: 03/05/2012

Category:

6.1.2 Antidiabetic drugs | Diabetes

NeLM Area:

News

Abstract
2.

AWMSG issues Final Appraisal Recommendation on linagliptin (Trajenta®)

Source: All Wales Medicines Strategy Group (AWMSG),
Date published: 01/05/2012

Category:

6.1.2 Antidiabetic drugs | All Wales Medicines Strategy Group (AWMSG) | Diabetes

NeLM Area:

Evidence > Drug Specific Reviews

Link
3.

TODAY study shows children and adolescents require combination antidiabetic therapy early after diagnosis of type 2 diabetes

Source: NEJM,
Date published: 30/04/2012

Category:

6.1.2 Antidiabetic drugs | Adolescents (11-18 years) | Children (2-11 years) | Diabetes | Drugs in paediatrics

NeLM Area:

News

Abstract

Editorial
4.

Horizon scanning: FDA requests further data on diabetes drug alogliptin

Source: PharmaTimes,
Date published: 27/04/2012

Category:

6.1.2 Antidiabetic drugs | Diabetes | Food &Drug Administration (FDA) | New drugs

NeLM Area:

News

PharmaTimes story (registration required)
5.

Family support, medication adherence, and glycemic control among adults with Type 2 diabetes

Source: Diabetes Care,
Date published: 27/04/2012

Category:

6.1.2 Antidiabetic drugs | Compliance | Diabetes

NeLM Area:

Evidence > Medicines Management > References

Abstract link
6.

European CHMP adopts positive opinion on dapagliflozin (Forxiga®) for type 2 diabetes mellitus

Source: European Medicines Agency (EMA),
Date published: 23/04/2012

Category:

6.1.2 Antidiabetic drugs | Diabetes | European Agency for the Evaluation of Medicinal Products (EMEA) | New drugs

NeLM Area:

News

Link
7.

Systematic review and meta-analyses: Comparison of metformin and insulin versus insulin alone for type 2 diabetes

Source: BMJ,
Date published: 20/04/2012

Category:

6.1.1 Insulins | 6.1.2 Antidiabetic drugs | Diabetes

NeLM Area:

News

Full text of article (available freely at time of posting)
8.

Cardiovascular, ocular and bone adverse reactions associated with thiazolidinediones: a disproportionality analysis of the US FDA Adverse Event Reporting System database

Source: Drug Safety,
Date published: 20/04/2012

Category:

6.1.2 Antidiabetic drugs

NeLM Area:

Evidence > Medicines Management > References

Abstract link
9.

New drugs and the growth of health expenditure: evidence from diabetic patients in Taiwan

Source: Health Economics,
Date published: 20/04/2012

Category:

6.1.2 Antidiabetic drugs | Health Economics

NeLM Area:

Evidence > Medicines Management > References

Abstract link
10.

Byetta (exenatide) solution for injection - Revised SPC

Source: eMC (electronic Medicines Compendium),
Date published: 19/04/2012

Category:

6.1.2 Antidiabetic drugs | Diabetes | Product Licence Changes

NeLM Area:

Other Library Updates > SPC Changes

SPC

Results 1 - 10 of 594

Result page:
Previous
|
1
2
3
4
5
6
7
8
9
10
11
|
Next